Home PATIENT INFO

Patient Info

Suffering from Acid Reflux? Tired of Medication?

Introducing a new, incisionless treatment of reflux

A novel system (SRS™) enables a minimally invasive procedure that can provide long lasting relief and improved quality of life for people suffering from acid reflux.The SRS™-based procedure can stop or significantly reduce symptoms such as: irritation, heartburn and potentially other severe conditions related to acid reflux.
  • An incisionless treatment of Reflux
  • Can provide immediate relief of irritating symptoms such as heart burn
  • Can allow significant reduction in medication intake

medigus-gerd-treatment-halapinio

About GERD

gerd-patientGastroesophageal reflux disease (GERD) occurs when the lower esophageal sphincter opens spontaneously or does not close properly and stomach contents rise up into the esophagus, causing irritation, acid reflux, heartburn and potentially other severe conditions. GERD is usually treated with acid reducing medications, which prevent the symptoms but do not cure the disease.

Read more...

THE SRS SYSTEM

gerd-treatmentMedigus’ SRS™ is a revolutionary system for incisionless treatment of GERD, enabling physicians to perform reconstruction of the esophageal valve through the mouth, eliminating the need for full-scale surgery in eligible patients.

Read more...

Questions and Answers

9297753-faqIs this the right treatment for me? 
If you are 18 years old or older;  were diagnosed with chronic reflux disease (GERD) or have a history of heartburn symptoms for an extended amount of time; and have been using antacid medications daily for at least 6 months with some relief of symptoms, you may benefit from the SRS™ treatment.  

Read more...

Experts recommend the SRS™-based procedure

Medigus Patient leaflet Reflux doctor"At 3 years, the procedure remained effective in improving the quality of life in moderate to severe GERD without causing dysphagia. PPI use was eliminated or reduced in 73% of subjects. All subjects remain satisfied with the procedure and would do it all over again."

Read more...

GERD / Acid reflux treatment

7374092 sThere are a number of treatment options available for GERD. Changes in behavior and lifestyle change may lead to suppression of GERD symptoms, There are different types of drugs that may reduce or minimize GERD symptoms as well as surgery... 

Read more...

Medigus

Medigus is a medical device company specializing in developing innovative endoscopic procedures and devices, including the revolutionary disposable endoscope for the treatment of GERD (Gastroesophageal Reflux Disease).

The company, which was founded in January 2000, is based in Israel and is publicly traded on the TASE. Medigus owns a unique and outstanding technological platform enabling the company to bring into the world state-of-the-art medical device products.

Read more

News

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Prev Next

EAES European Association for Endoscopic Surgery

21-05-2013

June 19-22, 2013
Vienna, Austria
Visit us at booth #25

Read more

Successful Three-Year Follow-Up Data of the SRS™ Pivotal Study in Indiana University Will be Presented at the Digestive Disease Week in Orlando

16-05-2013

Medigus Ltd. (MDGS.TA), a leading medical device company dedicated to the development of innovative endoscopic procedures and technologies, will be presenting the successful three year follow-up da...

Read more

DDW Digestive Disease Week

06-05-2013

May 18-21, 2013
Orlando, Florida

Read more

Successful five-year follow-up data from SRS™ pilot study

05-05-2013

Medigus (TASE:MDGS) announced today that it had received five-year follow-up results of a pilot study of its SRS™ endoscopic system for the treatment of Gastroesophageal Reflux Disease (GERD). The ...

Read more

Medigus Signed a Distribution Agreement in China

12-03-2013

Local distributor to purchase SRS™II systems for a minimum of $3.85 million.

Read more

Medigus completed $8M private placement by OrbiMed

04-03-2013

Medigus (TASE:MDGS) announces that it had closed an $8 million investment by OrbiMed Israel Partners LP. Upon the closing of the investment, Dr. Nissim Darvish, senior managing director at OrbiMed ...

Read more

Columbia Medical Center Offers SRS Procedures

13-02-2013

Medigus (TASE:MDGS) announces that Columbia University Medical Center, Department of Surgery (New-York, New-York), now offers the SRS™ procedure for transoral incisionless treatment of GERD.

Read more

Medigus announces an exclusive distribution agreement for the SRS™II in Turkey

16-01-2013

Medigus (TASE:MDGS) announces an exclusive distribution agreement for the SRS™II in Turkey.

Read more